The Journal of Heart Valve Disease publishes peer-reviewed scientific communications pertaining to heart valves and heart valve disease, including but not limited to all issues related to the scientific activity of The Society for Heart Valve Disease. These encompass all relevant clinical, surgical and laboratory specialties, multicenter trials, morphology, physiology, molecular biology, pathology as well as design, materials, test data and performances of replacement devices, relevant instruments and equipment. The scope of articles includes original publications, editorials, current and collective reviews, technical know-how papers both in surgery and cardiology, case reports, correspondence and book reviews.
Submission of a manuscript to the Journal implies the authors’ assertion that (a) it is original, (b) has not been published before and (c) is not under consideration, or under publication elsewhere. Prior publication of an abstract of 400 words or less does not prejudice the originality of a manuscript.
Manuscripts and all editorial correspondence should be sent electronically via our online submission platform by clicking here.
A manuscript will be evaluated not only with respect to its scientific competence and accuracy but also to its relative importance in the field of heart valve and heart valve disease and for its probable interest to our readership. Each manuscript will be reviewed by the Editor and/or Associate Editor and at least 2-3 additional outside reviewers. Invited reviewers will evaluate each manuscript based on the following criteria:
The importance of the research question as it pertains to heart valves and heart valve disease;
Analytical methods appropriate for data presented;
Data presented in a clear concise method;
Tables, figures, illustrations and references are appropriate for the topic;
Appropriate statistical methods applied and determination if statistical review should be considered;
Manuscript format and content
Are structure, content, grammatical, length and writing style consistent with guidelines;
Is the discussion section relevant;
Is the conclusion section reasonable and support the discussion.
Acknowledgement of manuscript receipt
The corresponding author will receive an acknowledgement by e-mail and an assigned unique tracking number. Any and all communication with the Editor regarding the status of a manuscript will be provided only to authors who identify the manuscript number. When corresponding with the editorial office manuscripts must be referenced using the assigned number.
Manuscript acceptance, revision and re-review
The corresponding author will be notified by e-mail about the acceptance of a manuscript. If it accepted only conditionally pending revision, the corresponding author will receive all reviewer comments together with the editor’s recommendations. Revised manuscripts must be submitted in three parts: 1) a cover letter that provides a point-by-point response to reviewers’ comments; 2) the revised manuscript containing the deletions noted strikethrough and additions in bold; 3) the unmarked revised manuscript. Revised manuscripts received after 3 months from the ‘Request to Revise” receipt date may be required to resubmit as a new manuscript and will be subject to the entire submission review process.
Manuscripts that have been either undergone substantial revision or contain techniques/technology of controversial topics or articles discussing complex issues are subject to re-review at the discretion of the Editor.
If the manuscript is accepted for publication in the Journal, the copyright of it must be transferred to ICR Publishers Ltd., and the copyright transfer document, which will be sent with the page proofs, should be signed by all authors of the article.
Manuscripts reporting on human studies must adhere to the principles of the Helsinki Declaration. Reports describing data obtained from research conducted in human participants must contain a statement in the Methods section indicating approval by the Institutional Review Board. If patients are identifiable from illustrations, photographs, study data or figures, release forms giving permission for publication must be submitted with the manuscript.
Manuscripts reporting experiments on living animals should adhere to the principles provided in the Guide for Care and Use of Laboratory Animals. Manuscripts should also include in the Methods section a statement by the authors that the relevant regulations of the country where the experiments were carried out were fully observed.
Conflict of interest
All authors submitting any type of communication to be considered for publication in the Journal are expected to disclose any type of commercial association that might pose a conflict of interest in connection with that communication. All sources of funding of the work should be declared and acknowledged in a footnote. If the corporate or institutional affiliation of an author might constitute a conflict of interest, this fact should be communicated with the Editor in writing when the manuscript is submitted.
The maximum number of authors is eight, except in the case of multicenter studies. If there are more than three authors, each author will be required to state the type of scientific participation in the work. This can be (a) conception or design of protocol, collection, assessment or interpretation of data, (b) drafting the manuscript or revising its contents and (c) approval of the final version to be sent for publication.
The language of the Journal is the American version of medical/technical English.
Checklist for manuscript preparation
Keep the length between 250 - 300 words for original publication and review articles, 150 - 200 words for case reports and other short communications. Organize the abstract in four major parts:
Tables should be self-explanatory and should supplement, not duplicate, the text. They should be typed on individual pages separate from the text. Provide a brief title for each. Abbreviations used in tables should be defined at the bottom of the table.
LETTER OF PERMISSION
Supply permission from both the publisher and the author to reproduce any previously published illustration or table. This letter of permission should be submitted at the time the final revised manuscript is submitted.
The Editors reserve all rights to make editorial revisions to aid clarity and understanding without altering the meaning.